News & Updates

Postoperative levels of high-sensitivity cardiac troponin T (hs-cTnT) often surpass defined cut-off values for myocardial infarction type 5 (MI-5; also known as peri-procedural MI), indicating the need to reassess current definitions, a recent study has found.

A moderate-intensity endurance and resistance exercise training programme results in better muscle performance, capillarization, and mitochondrial content in both asymptomatic and symptomatic statin users without exacerbating muscle complaints, a study has shown. In addition, exercise training may even improve quality of life in symptomatic statin users.

Bisoprolol does not seem to exert a significant protective effect against perioperative myocardial injury in patients undergoing noncardiac surgery, a recent study has found.

Heart failure with preserved ejection fraction (HFpEF) represents a significant unmet medical need. The EMPEROR-Preserved trial aimed to assess the impact of empagliflozin on cardiovascular outcomes in patients with HFpEF. On 27 August 2021, during the hotline session of the 2021 ESC Virtual Congress, the main results of the EMPEROR-Preserved trial were presented by Professor Stefan Anker, principal investigator of the study, and heart failure specialist at Charité Berlin, Germany.

The use of instantaneous wave-free ratio (iFR) to guide revascularization decisions continued to show similar outcomes in terms of all-cause mortality, myocardial infarction (MI), or unplanned revascularization in patients with stable angina or acute coronary syndrome (ACS) compared with fractional flow reserve (FFR) at 5 years, according to the iFR-SWEDEHEART* study presented at TCT 2021.

Postloading insulinaemia appears to be linked to arterial stiffness in young individuals, a recent Japan study has found. In contrast, insulin sensitivity (SI) shows no such effect.